Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

53 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Principles for Assessing Adversity in Toxicologic Clinical Pathology.
Ramaiah L, Tomlinson L, Tripathi NK, Cregar LC, Vitsky A, Beust BV, Barlow VG, Reagan WJ, Ennulat D. Ramaiah L, et al. Among authors: reagan wj. Toxicol Pathol. 2017 Feb;45(2):260-266. doi: 10.1177/0192623316681646. Epub 2017 Jan 5. Toxicol Pathol. 2017. PMID: 28056663 Review.
Response letter from Clinical Pathology Interest Group of the Society of Toxicologic Pathology (STP) for manuscript entitled International recommendations for training future toxicologic pathologists participating in regulatory-type, nonclinical toxicity studies by Bolon et al.
Tripathi NK, Schultze AE, Pearson RC, Everds NE, Elliott GS, Ramaiah L, Wells MY, Latimer KS, Walter GL, Katavolos P, Collins ND, Tarrant J, Walker DB, Topper MJ, Jordan HL, O'Rourke LG, Guilpin VB, Brockus CW, Wilcox AL, Clemo FA, Smith GS, Reagan WJ, McCartney JE. Tripathi NK, et al. Among authors: reagan wj. Exp Toxicol Pathol. 2013 Jan;65(1-2):39. doi: 10.1016/j.etp.2011.05.007. Epub 2011 Jun 15. Exp Toxicol Pathol. 2013. PMID: 21676604 No abstract available.
The use of emerging safety biomarkers in nonclinical and clinical safety assessment - The current and future state: An IQ DruSafe industry survey.
Zabka TS, Burkhardt J, Reagan WJ, Gautier JC, Glaab WE, Guffroy M, Harding J, Brees D, McDuffie E, Ramaiah L, Schultze AE, Smith JD, Wolfreys A, Dalmas DA. Zabka TS, et al. Among authors: reagan wj. Regul Toxicol Pharmacol. 2021 Mar;120:104857. doi: 10.1016/j.yrtph.2020.104857. Epub 2020 Dec 31. Regul Toxicol Pharmacol. 2021. PMID: 33387566 Free article.
Evaluation of Cardiac Toxicity Biomarkers in Rats from Different Laboratories.
Kim K, Chini N, Fairchild DG, Engle SK, Reagan WJ, Summers SD, Mirsalis JC; Cardiac Hypertrophy Working Group of the Predictive Safety Testing Consortium. Kim K, et al. Among authors: reagan wj. Toxicol Pathol. 2016 Dec;44(8):1072-1083. doi: 10.1177/0192623316668276. Epub 2016 Sep 28. Toxicol Pathol. 2016. PMID: 27638646 Free PMC article.
Comprehensive Nonclinical Safety Assessment of Nirmatrelvir Supporting Timely Development of the SARS-COV-2 Antiviral Therapeutic, Paxlovid™.
Sathish JG, Bhatt S, DaSilva JK, Flynn D, Jenkinson S, Kalgutkar AS, Liu M, Manickam B, Pinkstaff J, Reagan WJ, Shirai N, Shoieb AM, Sirivelu M, Vispute S, Vitsky A, Walters K, Wisialowski TA, Updyke LW. Sathish JG, et al. Among authors: reagan wj. Int J Toxicol. 2022 Aug;41(4):276-290. doi: 10.1177/10915818221095489. Epub 2022 May 21. Int J Toxicol. 2022. PMID: 35603517 Free PMC article.
53 results